There are currently 99 active clinical trials seeking participants for Endometrial Cancer research studies. The states with the highest number of trials for Autism participants are New York, Texas, California and Ohio.
Mindfulness in Endometrial and Cervical Cancer
NCT04512144
Recruiting
Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.
Gender:
Female
Ages:
Between 18 years and 90 years
Trial Updated:
09/08/2023
Locations: Saint Louis University, Saint Louis, Missouri
Conditions: Gynecologic Cancer, Endometrial Cancer, Cervical Cancer, Quality of Life, Opioid Use
Register for Updates
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
NCT04683653
Recruiting
This study will investigate if a shorter treatment course (known as "hypofractionation") for pelvic radiation is safe for women with endometrial cancer. Doctors leading the study will also determine the safest and most tolerable dose of shortened radiation (hypofractionation) used to treat women in this study. Because this study will shorten the radiation course typically used to treat endometrial cancer, each daily treatment given to women in this study will be slightly higher than normal to en... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
08/25/2023
Locations: University of Chicago, Chicago, Illinois
Conditions: Endometrial Cancer
Register for Updates
Methods for Increasing Genetic Testing Uptake in Michigan
NCT05162846
Recruiting
The primary purpose of this study is to compare three interventions, two experimental and one standard of care (usual care), to see if the experimental interventions will increase the likelihood of a participant obtaining guideline-concordant genetic testing. Eligible participants will be randomized (assigned) to one of the following interventions: 1) Virtual genetics navigator, a mobile-optimized website, designed by the investigators, that delivers tailored messages and content; 2) two motivat... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/17/2023
Locations: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Conditions: Breast Cancer, Colorectal Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Endometrial Cancer, History of Cancer
Register for Updates
Genetic Testing in African Americans
NCT05591131
Recruiting
This is a pilot/feasibility study to conduct genetic testing using tumor/blood samples of African American and Caucasian patients with ovarian and endometrial cancer following surgery at AU Health Medical Center. The aim of the pilot/feasibility study is to sequence a panel of cancer genes on paired tumor/blood (germline) samples of patients with ovarian and endometrial tumors at a two-week time point following surgery at AU Medical Center. While paired testing of tumor and blood (germline) prov... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/20/2023
Locations: Georgia Cancer Center at Augusta University, Augusta, Georgia
Conditions: Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer
Register for Updates
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
NCT00005095
Recruiting
RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
Gender:
Female
Ages:
Between 18 years and 80 years
Trial Updated:
06/13/2023
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois
Conditions: Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2), Ovarian Cancer, Sarcoma, Uterine Leiomyomata, Vaginal Cancer, Vulvar Cancer
Register for Updates
Abemaciclib + Letrozole +/- Metformin in Recurrent or Persistent Endometrial Cancer
NCT03675893
Recruiting
This research study is studying a combination of targeted therapies as a possible treatment for estrogen-receptor positive (ER+) endometrial cancer. The drugs involved in this study are: Abemaciclib (also known as Verzenio™) Letrozole (also known as Femara®) Metformin (also known as Glucophage®)
Gender:
Female
Ages:
18 years and above
Trial Updated:
06/12/2023
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts +2 locations
Conditions: Endometrial Cancer
Register for Updates
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
NCT04527900
Recruiting
A phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic compliance rate of the chemoradiation arm of GOG 258 study
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/02/2023
Locations: Maryland Proton Treatment Center, Baltimore, Maryland +3 locations
Conditions: Endometrial Cancer
Register for Updates
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
NCT04196257
Recruiting
This is a phase I, open-label, study of BP1001-A in participants with advanced or recurrent solid tumors. The dose escalation phase will determine the safety and the maximum tolerated dose (MTD) or maximum administered dose (MAD) of BP1001-A as a single agent. After the MTD or MAD of BP1001-A is established, the dose expansion phase will commence and determine the safety, toxicity and response of BP1001-A in combination with paclitaxel.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: Holy Cross Hospital, Silver Spring, Maryland +3 locations
Conditions: Solid Tumor, Adult, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Endometrial Cancer, Peritoneal Cancer, Solid Tumor
Register for Updates
Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers
NCT04570553
Recruiting
This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
Gender:
Female
Ages:
18 years and above
Trial Updated:
03/14/2023
Locations: Wellspan Health, York, Pennsylvania
Conditions: Endometrial Cancer
Register for Updates
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
NCT04514692
Recruiting
This is a research study using Granulocyte Colony Stimulating Factor (GCSF) as a bone marrow stimulating agent for imaging to guide radiation treatment planning. G-CSF is a type of growth factor. Growth factors are proteins made in the body. G-CSF is a type of growth factor that makes the bone marrow produce white blood cells to reduce the risk of infection after some types of cancer treatment.
Gender:
Female
Ages:
18 years and above
Trial Updated:
03/08/2023
Locations: Stanford Cancer Institute Palo Alto, Stanford, California
Conditions: Cervix Cancer, Endometrial Cancer
Register for Updates
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
NCT03748186
Recruiting
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Gender:
Female
Ages:
18 years and above
Trial Updated:
02/07/2023
Locations: Arizona Oncology - Tucson, Tucson, Arizona +26 locations
Conditions: Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Endometrial Cancer, Endometrioid Adenocarcinoma, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Register for Updates
Vaginal Cuff Brachytherapy Fractionation Study
NCT03785288
Recruiting
The purpose of this study is to see the effects of two different standard of care treatments of endometrial cancer on sexual dysfunction. This study will compare two standard of care treatments: HDR (high dose radiation) vaginal brachytherapy 3 fractions of 7 Gy to HDR vaginal brachytherapy 6 fractions of 4Gy for early stage endometrial cancer.
Gender:
Female
Ages:
18 years and above
Trial Updated:
01/19/2023
Locations: University of Maryland Medical Center (UMMC), Baltimore, Maryland +2 locations
Conditions: Endometrial Cancer
Register for Updates